{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:34:38Z","timestamp":1760747678491,"version":"build-2065373602"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,17]]},"DOI":"10.7759\/cureus.94813","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:38:02Z","timestamp":1760729882000},"source":"Crossref","is-referenced-by-count":0,"title":["Cutaneous Squamous Cell Carcinoma Mimicking Kaposi Sarcoma in an HIV-Positive Patient: Diagnostic Challenges and Therapeutic Response to Liposomal Doxorubicin"],"prefix":"10.7759","author":[{"given":"Ana de Lourdes","family":"Torralbas Fitz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio  J","family":"Torralbas Fitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliany","family":"Leon Figueredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Blanco Espinosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idania Maria","family":"Cruzata Matos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edurne","family":"C\u00e1rdenas Ferrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-3628","article-title":"Risk factors and prognosis for metastatic cutaneous squamous cell carcinoma: a cohort study","volume":"100","author":"Knuutila JS","year":"2020","unstructured":"Knuutila JS, Riihil\u00e4 P, Kurki S, Nissinen L, K\u00e4h\u00e4ri VM. Risk factors and prognosis for metastatic cutaneous squamous cell carcinoma: a cohort study. Acta Derm Venereol. 2020, 100:adv00266. 10.2340\/00015555-3628","journal-title":"Acta Derm Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2023.113251","article-title":"European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023","volume":"193","author":"Stratigos AJ","year":"2023","unstructured":"Stratigos AJ, Garbe C, Dessinioti C, et al.. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention-Update 2023. Eur J Cancer. 2023, 193:113251. 10.1016\/j.ejca.2023.113251","journal-title":"Eur J Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16101800","article-title":"Cutaneous squamous cell carcinoma: an updated review","volume":"16","author":"Jiang R","year":"2024","unstructured":"Jiang R, Fritz M, Que SK. Cutaneous squamous cell carcinoma: an updated review. Cancers (Basel). 2024, 16:10.3390\/cancers16101800","journal-title":"Cancers (Basel)"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/der2.132","article-title":"Cutaneous cancers in the Africans: systematic review","volume":"3","author":"Ayanlowo OO","year":"2022","unstructured":"Ayanlowo OO, Adegbulu AA, Cole-Adeife O. Cutaneous cancers in the Africans: systematic review. Dermatol Rev. 2022, 3:369-81. 10.1002\/der2.132","journal-title":"Dermatol Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1523169","article-title":"Global, regional, national prevalence, mortality, and disability-adjusted life-years of cutaneous squamous cell carcinoma and trend analysis from 1990 to 2021 and prediction to 2045","volume":"15","author":"Liu C","year":"2025","unstructured":"Liu C, Liu X, Cao P, Li X, Xin H, Zhu S. Global, regional, national prevalence, mortality, and disability-adjusted life-years of cutaneous squamous cell carcinoma and trend analysis from 1990 to 2021 and prediction to 2045. Front Oncol. 2025, 15:1523169. 10.3389\/fonc.2025.1523169","journal-title":"Front Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.689789","article-title":"Non-melanoma skin cancer in people living with HIV: from epidemiology to clinical management","volume":"11","author":"Venanzi Rullo E","year":"2021","unstructured":"Venanzi Rullo E, Maimone MG, Fiorica F, Ceccarelli M, Guarneri C, Berretta M, Nunnari G. Non-melanoma skin cancer in people living with HIV: from epidemiology to clinical management. Front Oncol. 2021, 11:689789. 10.3389\/fonc.2021.689789","journal-title":"Front Oncol"},{"key":"ref7","article-title":"Doxorubicin","author":"Johnson-Arbor K","year":"2025","unstructured":"Johnson-Arbor K. Doxorubicin. StatPearls [Internet]. Dubey R (ed): StatPearls Publishing, Treasure Island; 2025 Jan-."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.90070","article-title":"Disseminated Kaposi sarcoma with ocular involvement: an unusual multisystem case presentation","volume":"17","author":"Torralbas Fitz AL","year":"2025","unstructured":"Torralbas Fitz AL, Cruzata Matos IM, Torralbas Fitz SJ, Leon Figueredo E, Blanco Espinosa E. Disseminated Kaposi sarcoma with ocular involvement: an unusual multisystem case presentation. Cureus. 2025, 17:e90070. 10.7759\/cureus.90070","journal-title":"Cureus"},{"key":"ref9","article-title":"Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging","volume":"78","author":"Que SKT","year":"2018","unstructured":"Que SKT, Zwald FO, Schmults CD. Cutaneous squamous cell carcinoma: incidence, risk factors, diagnosis, and staging. J Am Acad Dermatol. 2018, 78:237-247.","journal-title":"J Am Acad Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.9.1201","article-title":"Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee","volume":"7","author":"Krown SE","year":"1989","unstructured":"Krown SE, Metroka C, Wernz JC. Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol. 1989, 7:1201-7. 10.1200\/JCO.1989.7.9.1201","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200103293441306","article-title":"Cutaneous squamous-cell carcinoma","volume":"344","author":"Alam M","year":"2001","unstructured":"Alam M, Ratner D. Cutaneous squamous-cell carcinoma. N Engl J Med. 2001, 344:975-83. 10.1056\/NEJM200103293441306","journal-title":"N Engl J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25362","article-title":"Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy","volume":"116","author":"Cianfrocca M","year":"2010","unstructured":"Cianfrocca M, Lee S, Von Roenn J, et al.. Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliation from chemotherapy. Cancer. 2010, 116:3969-77. 10.1002\/cncr.25362","journal-title":"Cancer"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.12-1-114","article-title":"A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma","volume":"12","author":"Cooley T","year":"2007","unstructured":"Cooley T, Henry D, Tonda M, Sun S, O'Connell M, Rackoff W. A randomized, double-blind study of pegylated liposomal doxorubicin for the treatment of AIDS-related Kaposi's sarcoma. Oncologist. 2007, 12:114-23. 10.1634\/theoncologist.12-1-114","journal-title":"Oncologist"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.04.018","article-title":"Treatments for classic Kaposi sarcoma: a systematic review of the literature","volume":"68","author":"R\u00e9gnier-Rosencher E","year":"2013","unstructured":"R\u00e9gnier-Rosencher E, Guillot B, Dupin N. Treatments for classic Kaposi sarcoma: a systematic review of the literature. J Am Acad Dermatol. 2013, 68:313-31. 10.1016\/j.jaad.2012.04.018","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.2.342","article-title":"Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy","volume":"8","author":"Guthrie TH Jr","year":"1990","unstructured":"Guthrie TH Jr, Porubsky ES, Luxenberg MN, Shah KJ, Wurtz KL, Watson PR. Cisplatin-based chemotherapy in advanced basal and squamous cell carcinomas of the skin: results in 28 patients including 13 patients receiving multimodality therapy. J Clin Oncol. 1990, 8:342-6. 10.1200\/JCO.1990.8.2.342","journal-title":"J Clin Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009932","article-title":"Oral leukoplakia, a precancerous lesion of squamous cell carcinoma, in patients with long-term pegylated liposomal doxorubicin treatment","volume":"97","author":"Nomura H","year":"2018","unstructured":"Nomura H, Sakamoto K, Sugihara T, et al.. Oral leukoplakia, a precancerous lesion of squamous cell carcinoma, in patients with long-term pegylated liposomal doxorubicin treatment. Medicine (Baltimore). 2018, 97:e9932. 10.1097\/MD.0000000000009932","journal-title":"Medicine (Baltimore)"},{"key":"ref17","unstructured":"Study details | NCT05377905 | Microneedle array plus doxorubicin in cutaneous squamous cell cancer (cSCC) | ClinicalTrials.gov. (2025). Accessed. October 17, 2025: https:\/\/clinicaltrials.gov\/study\/NCT05377905."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/417256-cutaneous-squamous-cell-carcinoma-mimicking-kaposi-sarcoma-in-an-hiv-positive-patient-diagnostic-challenges-and-therapeutic-response-to-liposomal-doxorubicin","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T19:38:04Z","timestamp":1760729884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/417256-cutaneous-squamous-cell-carcinoma-mimicking-kaposi-sarcoma-in-an-hiv-positive-patient-diagnostic-challenges-and-therapeutic-response-to-liposomal-doxorubicin"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.94813","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,17]]}}}